Lacosamide Solution
Product Images NDC 72205-034

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 72205-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novadoz Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-structure (Lacosamide Structure)

Chemical structure of Lacosamide, illustrating its molecular components and bonds as provided in the product data for the oral solution form.*

FDA Label Image

Lacosamide-fig-1 (Lacosamide Fig 1)

A bar chart titled 'Median Percent Reduction in Seizure Frequency per 28 days from Baseline to the Maintenance Phase by Dose' showing seizure reduction percentages for Lacosamide oral solution versus placebo across three studies with different dosages. The y-axis represents seizure reduction percentage ranging from 0% to 45%. Bars represent median percent reduction for placebo and multiple Lacosamide doses (200, 400, 600 mg/day) with generally higher seizure reduction in Lacosamide groups across studies, and statistical significance indicated for several comparisons.*

FDA Label Image

Lacosamide-fig-2 (Lacosamide Fig 2)

A cumulative responder rate graph depicting the proportion of patients by responder rate for Lacosamide and placebo groups in studies 2, 3, and 4. The y-axis shows responder rate from -100% (worsening) to 100% (improvement), while the x-axis represents percent of patients from 100% to 0%. The graph includes separate lines for placebo and three Lacosamide dosage groups: 200 mg/day, 400 mg/day (266 patients), and 400 mg/day (202 patients).*

FDA Label Image

Lacosamide-fig-3 (Lacosamide Fig 3)

A Kaplan-Meier survival curve graph comparing the proportion of patients over time (days) between two groups: Placebo (N=121) and Vimpat (N=118). The graph shows patient survival proportions decreasing over approximately 170 days, with Vimpat demonstrating a higher proportion of surviving patients than placebo. Additional data include risk numbers at various time points, a p-value of 0.001, hazard ratio (HR) of 0.548 indicating a 45.2% risk reduction, and a 95% confidence interval [0.381, 0.788].*

FDA Label Image

Lacosamide-200ml-bottle (Lacosamide 200ml Bottle)

Label for Lacosamide Oral Solution, USP 10 mg/mL, a 200 mL oral solution prescription drug. The label includes storage instructions, dosage referencing the package insert, and manufacturer and distributor information, listing MSN Pharmaceuticals Inc. as manufacturer and Novadoz Pharmaceuticals LLC as distributor. Includes barcodes and a pharmacist advisory for dispensing the medication guide.*

FDA Label Image

Lacosamide-465ml-bottle (Lacosamide 465ml Bottle)

Label for Lacosamide Oral Solution USP 10 mg/mL, a human prescription drug oral solution. The 465 mL bottle label includes storage instructions (20°C to 25°C), discard warning after six months of opening, pharmacist dispensing guidance, manufacturer MSN Pharmaceuticals Inc., and distributor Novadoz Pharmaceuticals LLC contact information. The label is marked Rx only with barcode and NDC 72205-034-75.*

FDA Label Image

Lacosamide-5ml-unit-dose-cup10s-outer-carton (Lacosamide 5ml Unit Dose Cup10s Outer Carton)

Packaging label for Lacosamide Oral Solution, USP with a strength of 50 mg/5 mL. The product is provided as 10 x 5 mL unit dose cups. The label shows it is Rx only and is manufactured by MSN Pharmaceuticals Inc., distributed by Novadoz Pharmaceuticals LLC. The NDC is 72205-034-50 and the label includes a barcode and medication guide instructions for pharmacists.*

FDA Label Image

Lacosamide-5ml-unit-dose-cupfoil (Lacosamide 5ml Unit Dose Cupfoil)

Label for Lacosamide Oral Solution, USP 50 mg/5 mL, for institutional use only. The product delivers 5 mL per dose and is supplied by Novadoz Pharmaceuticals LLC, Piscataway, NJ. The label includes storage instructions, an NDC number (72205-034-44), lot number, expiration date, and a barcode.*

FDA Label Image

Lacosamide-10ml-unit-dose-cup10s-outer-carton (Lacosamide 10ml Unit Dose Cup10s Outer Carton)

Packaging label for Lacosamide Oral Solution, USP, 100 mg/10 mL, in 10 x 10 mL unit dose cups. The label indicates it is for prescription use only and is distributed by Novadoz Pharmaceuticals LLC. The label includes dosage instructions for pharmacists and manufacturing details.*

FDA Label Image

Lacosamide-10ml-unit-dose-cup-foill (Lacosamide 10ml Unit Dose Cup Foil)

Label for Lacosamide Oral Solution USP 100 mg/10 mL, an oral solution distributed by Novadoz Pharmaceuticals LLC. The label includes storage instructions, a barcode, and identifies the product as prescription only with a specified NDC 72205-034-45.*

FDA Label Image

Lacosamide-15ml-unit-dose-cup10s-outer-carton. (Lacosamide 15ml Unit Dose Cup10s Outer Carton)

Packaging label for Lacosamide Oral Solution, USP, 150 mg per 15 mL, by Novadoz Pharmaceuticals LLC. The label is for a product supplied in 10 unit dose cups of 15 mL each. It includes NDC 72205-034-93 and instructions for pharmacists to dispense an accompanying medication guide.*

FDA Label Image

Lacosamide-15ml-unit-dose-cupfoil (Lacosamide 15ml Unit Dose Cupfoil)

Label for Lacosamide Oral Solution USP, 150 mg per 15 mL, distributed by Novadoz Pharmaceuticals LLC. The label indicates the product is for institutional use only, with storage instructions between 20°C to 25°C, and shows an NDC number 72205-034-46. The label includes barcodes and space for lot and expiration dates.*

FDA Label Image

Lacosamide-20ml-unit-dose-cup10s-outer-carton. (Lacosamide 20ml Unit Dose Cup10s Outer Carton)

Packaging label for Lacosamide Oral Solution, USP, 200 mg/20 mL, in 10 unit dose cups of 20 mL each. The label shows the proprietary and generic name, strength, dosage form, and manufacturer details. It is labeled for Rx only and includes directions for pharmacists to dispense an accompanying Medication Guide. Distributed by Novadoz Pharmaceuticals LLC.*

FDA Label Image

Lacosamide-20ml-unit-dose-cupfoil. (Lacosamide 20ml Unit Dose Cupfoil)

Label for Lacosamide Oral Solution USP 200 mg/20 mL, an oral solution delivered in 20 mL volume. The label indicates prescription use only and storage instructions between 20°C to 25°C with permitted excursions. Distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ. Includes a barcode and spaces for lot number, expiration date, and issue date.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.